Barclays Boosts Aviva (OTCMKTS:AVVIY) Price Target to GBX 565

Aviva (OTCMKTS:AVVIYGet Rating) had its target price lifted by Barclays from GBX 564 ($6.67) to GBX 565 ($6.68) in a research report report published on Tuesday, The Fly reports.

A number of other analysts have also issued reports on the stock. Credit Suisse Group increased their price target on shares of Aviva from GBX 455 ($5.38) to GBX 480 ($5.68) in a research report on Monday, August 15th. JPMorgan Chase & Co. increased their price target on Aviva from GBX 510 ($6.03) to GBX 535 ($6.33) in a report on Thursday, November 10th. Morgan Stanley lowered their price objective on shares of Aviva from GBX 2,700 ($31.93) to GBX 2,675 ($31.63) in a research note on Friday, July 29th. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Aviva from GBX 520 ($6.15) to GBX 485 ($5.73) in a research note on Thursday, October 27th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, Aviva has a consensus rating of Hold and a consensus price target of $810.00.

Aviva Stock Performance

OTCMKTS:AVVIY opened at $10.98 on Tuesday. Aviva has a twelve month low of $8.05 and a twelve month high of $15.96. The company has a 50-day moving average of $9.52 and a 200-day moving average of $9.86.

About Aviva

(Get Rating)

Aviva plc provides various insurance, retirement, investment, and savings products in the United Kingdom, Ireland, Canada, and internationally. The company offers life insurance, long-term health and accident insurance, savings, pension, and annuity products, as well as pension fund business and lifetime mortgage products.

Read More

The Fly logo

Analyst Recommendations for Aviva (OTCMKTS:AVVIY)

Receive News & Ratings for Aviva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aviva and related companies with MarketBeat.com's FREE daily email newsletter.